Skip to main content
graph.swiss
Novartis AG

Novartis AG

124.60 CHF+1.92 (+1.57%)
XSWX:NOVNEEMarket Closed
ListedCHF242.2BHealthcareDrug Manufacturers - General75,267 employees

Company Profile

Legal NameNovartis AG
HeadquartersLichtstrasse 35
Phone41 61 324 11 11
Employees (FTE)75,267
SectorHealthcare
IndustryDrug Manufacturers - General

Other Listings & Derivatives(1)

Business Description

Novartis AG is a global healthcare company based in Switzerland, specializing in the research and development of pharmaceutical products. Functioning at the forefront of the medical innovation landscape, Novartis is dedicated to discovering new ways to improve and extend people’s lives. The company is predominantly renowned for its pioneering work in the pharmaceutical and biotechnology sectors, producing a wide range of drugs that tackle common and rare diseases alike. Novartis’s diverse portfolio includes advanced treatments in oncology, immunology, dermatology, respiratory, ophthalmology, and neuroscience, among others. Through its substantial investment in research and development, Novartis fuels the advancement of medicine, contributing significantly to medical breakthroughs and patient care improvements worldwide. As a major player in the healthcare industry, Novartis not only serves as a key provider of essential pharmaceuticals but also plays a vital role in shaping global health outcomes through innovation and collaborations across various sectors.

Profitability & Growth

Profitability

Profit Margin+23.92%
Operating Margin+30.48%
Return on Equity (TTM)+34.93%
Return on Assets (TTM)+10.54%

Recent Year-End

Revenue45.79B
Revenue / Share29.40
Gross Profit34.60B
EBITDA22.40B
Diluted EPS5.63
Earnings Growth YoY-12.50%
Revenue Growth YoY-0.70%

Balance Sheet Snapshot

Total Cash (MRQ)

5.58B

Total Debt (MRQ)

38.04B

Current Ratio (MRQ)

0.85

Book Value / Share

16.09

Stock Statistics

Shares Outstanding1.91B
Float Shares1.86B
Avg Volume (10d)129.9K
Avg Volume (90d)130.0K

Valuation

Market Cap242.20B
Enterprise Value221.58B
Trailing P/E21.79
Price / Sales (TTM)4.21
Price / Book (MRQ)7.63
EV / Revenue4.84
EV / EBITDA11.94

Price Summary

52-Week Low91.36
52-Week High130.54
50-Day MA120.49
200-Day MA119.82
Beta0.49

Dividends

Trailing Div Rate4.67